Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 2, 2017-07 ,pp. : 135-140

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 3, 2017-10 ,pp. : 172-177

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Acting Drugs in Treatment of Migraine Headache

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Strategies to Predict Effect of P-Glycoprotein Transporter Efflux and Minimize its Impact on the Penetration of Drugs into the Central Nervous System (CNS)

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-03 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite

A novel, dynamic in vitro model of the blood-brain barrier (BBB) to predict central nervous system (CNS) accumulation of novel therapeutics (stroke, Alzheimer’s, epilepsy)

By Janigro D.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 257-260

Informa Healthcare

Access to resources Recommend Favorite